These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30290461)

  • 1. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; Schüle C; Zwanzger P; Rupprecht R
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):517-526. PubMed ID: 30290461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.
    Eser D; Schüle C; Romeo E; Baghai TC; di Michele F; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Psychopharmacology (Berl); 2006 Jun; 186(3):373-87. PubMed ID: 16247651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroactive steroids and affective disorders.
    Eser D; Schüle C; Baghai TC; Romeo E; Uzunov DP; Rupprecht R
    Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V; Sampson L; Uzunov DP
    Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroactive steroids as endogenous modulators of anxiety.
    Eser D; Baghai TC; Schüle C; Nothdurfter C; Rupprecht R
    Curr Pharm Des; 2008; 14(33):3525-33. PubMed ID: 19075729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
    Rupprecht R
    Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
    Baghai TC; di Michele F; Schüle C; Eser D; Zwanzger P; Pasini A; Romeo E; Rupprecht R
    Neuropsychopharmacology; 2005 Jun; 30(6):1181-6. PubMed ID: 15702138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive steroids in neuropsychopharmacology.
    Rupprecht R; Holsboer F
    Int Rev Neurobiol; 2001; 46():461-77. PubMed ID: 11599310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
    Padberg F; di Michele F; Zwanzger P; Romeo E; Bernardi G; Schüle C; Baghai TC; Ella R; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2002 Nov; 27(5):874-8. PubMed ID: 12431862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroactive steroid actions at the GABAA receptor.
    Lan NC; Gee KW
    Horm Behav; 1994 Dec; 28(4):537-44. PubMed ID: 7729823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology.
    Rupprecht R; di Michele F; Hermann B; Ströhle A; Lancel M; Romeo E; Holsboer F
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):59-67. PubMed ID: 11744074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of endogenous neuroactive steroids.
    Reddy DS
    Crit Rev Neurobiol; 2003; 15(3-4):197-234. PubMed ID: 15248811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons.
    Gee KW; McCauley LD; Lan NC
    Crit Rev Neurobiol; 1995; 9(2-3):207-27. PubMed ID: 8581984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A; Romeo E; di Michele F; Pasini A; Yassouridis A; Holsboer F; Rupprecht R
    Am J Psychiatry; 2002 Jan; 159(1):145-7. PubMed ID: 11772707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antidepressant treatment on neuroactive steroids in major depression.
    Romeo E; Ströhle A; Spalletta G; di Michele F; Hermann B; Holsboer F; Pasini A; Rupprecht R
    Am J Psychiatry; 1998 Jul; 155(7):910-3. PubMed ID: 9659856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.